ArticleFrontiers in medicine2021

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study.

Sara Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.